Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of biologically active molecules and drug candidates. Its structure incorporates a protected amine group and a strained azetidine ring, making it valuable for constructing peptidomimetics and optimizing pharmacokinetic properties in medicinal chemistry. Commonly employed in the preparation of protease inhibitors and other targeted therapies where ring constraints influence potency and selectivity.